Amgen Anniversary Brings New Battle To Supreme Court
By Michael Lipkin
Law360, Los Angeles (February 27, 2014, 8:54 PM ET) -- A year after the U.S. Supreme Court rejected Amgen Inc.'s effort to raise the certification standards for securities fraud plaintiffs, attorneys say the case has helped pave the way for next week's Halliburton Co. Supreme Court showdown over the 25-year-old fraud-on-the-market theory underlying modern securities suits.
The court ruled one year ago Thursday that plaintiffs in securities fraud suits do not have to prove that allegedly misleading statements are material to their case in order to certify their class. But four justices in a dissent and...